3-methylcholanthrene and purvalanol a

3-methylcholanthrene has been researched along with purvalanol a in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Arisan, ED; Coker-Gurkan, A; Guvenir, E; Obakan, P; Unsal, NP	1

Other Studies

1 other study(ies) available for 3-methylcholanthrene and purvalanol a

Article	Year
Inhibition of autophagy by 3-MA potentiates purvalanol-induced apoptosis in Bax deficient HCT 116 colon cancer cells. Experimental cell research, 2014, Oct-15, Volume: 328, Issue:1 Topics: Antineoplastic Agents; Apoptosis; Autophagy; bcl-2-Associated X Protein; Blotting, Western; CDC2 Protein Kinase; Cell Cycle; Cell Proliferation; Colonic Neoplasms; Cyclin-Dependent Kinases; Drug Synergism; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Humans; Immunoprecipitation; Membrane Potential, Mitochondrial; Methylcholanthrene; Purines; Roscovitine; Tumor Cells, Cultured	2014

Article

Year

Inhibition of autophagy by 3-MA potentiates purvalanol-induced apoptosis in Bax deficient HCT 116 colon cancer cells.

Experimental cell research, 2014, Oct-15, Volume: 328, Issue:1

Topics: Antineoplastic Agents; Apoptosis; Autophagy; bcl-2-Associated X Protein; Blotting, Western; CDC2 Protein Kinase; Cell Cycle; Cell Proliferation; Colonic Neoplasms; Cyclin-Dependent Kinases; Drug Synergism; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Humans; Immunoprecipitation; Membrane Potential, Mitochondrial; Methylcholanthrene; Purines; Roscovitine; Tumor Cells, Cultured

2014